Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2005
08/04/2005US20050171339 Method of stabilizing protein
08/04/2005US20050171338 Mammalian tribbles signaling pathways and methods and reagents related thereto
08/04/2005US20050171337 Soluble interleukin-1 receptor accessory molecule
08/04/2005US20050171336 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
08/04/2005US20050171335 Novel antimicrobial peptide and use thereof
08/04/2005US20050171286 Copolymer-1 improvements in compositions of copolymers
08/04/2005US20050171047 Immunostimulatory nucleic acid molecules
08/04/2005US20050171046 Enhanced secretion / retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide
08/04/2005US20050171044 Oligonucleotide compound and method for treating nidovirus infections
08/04/2005US20050171020 Growth factor polypeptides and nucleic acids encoding same
08/04/2005US20050171019 Administering an exendin modified with a polymer such as polyethylene glycol, gelatin and/or albumin to increase its biological half-life; treating hyperglucagonemia and diabetes, especially type II diabetes
08/04/2005US20050171018 Novel polypeptide and gene encoding the same
08/04/2005US20050171017 As antiinflammatory agent alone or in combinaton; side effect reduction of glucocorticoid treatment; acute or chronic inflammation such as autoimmune disease, allergies, asthma, chronic obstructive pulmonary disease, psoriasis, dermatitis, Inflammatory Bowel disease
08/04/2005US20050171016 Thrombospondin-2 and uses thereof
08/04/2005US20050171014 ligand, a linker, and a cytotoxic agent, in which the linker is FALA; cell-targeted cancer therapy
08/04/2005US20050171013 inducing angiogenesis, stimulate hypoxia inducible factor-1 (HIF-1) alpha function, and treating hypoxia-related conditions such as ischemia, coronary heart disease, wound healing, stroke, or diabetic ulceration; plasmids, vectors and host cells
08/04/2005US20050171012 Preventives/remedies for bone/joint diseases
08/04/2005US20050171008 Monomeric insulin
08/04/2005US20050171007 Therapeutic method
08/04/2005US20050170511 Oxa1p enhanced protein secretion
08/04/2005US20050170504 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins
08/04/2005US20050170500 Methods for identifying risk of melanoma and treatments thereof
08/04/2005US20050170468 Anti-IL-20 receptor antibodies and binding partners and methods of using in inflammation
08/04/2005US20050170467 Nucleic acid sequences for polypeptides that inhibit endothelial cell growth; PRO Polypeptides; homology to Fibroblast Growth Factor-8 (FGF-8); vectors, host cells, primers and probes
08/04/2005US20050170466 Equine Fc epsilon receptor alpha protein
08/04/2005US20050170465 Nucleotide sequences coding transport proteins for identifying modulators for prevention and treatment of cell proliferative, nervous system, skin and inflammatory disorders
08/04/2005US20050170463 Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins
08/04/2005US20050170461 Identifying modulators which modify ligand protein binding for human pitutary and/or mouse pancreas-derived G protein-coupled receptorl treating nervous system and infectious disorders
08/04/2005US20050170459 Thymic stromal lymphopoietin receptor molecules and uses thereof
08/04/2005US20050170458 Inhibiting endothelial cell growth
08/04/2005US20050170457 Novel recombinant proteins with N-terminal free thiol
08/04/2005US20050170456 Expression vector for improving transcription of bacillus sequences in host cells; bioreactors
08/04/2005US20050170455 Novel prokineticin receptor isoforms and methods of use
08/04/2005US20050170452 Method to engineer mammanlian-type carbohydrate structures
08/04/2005US20050170440 Treatment and diagnosis of insulin-resistant states
08/04/2005US20050170436 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen
08/04/2005US20050170428 Enhanced inserted yellow fluorescence protein and its application
08/04/2005US20050170424 Oncoprotein specific immunoglobulin for use as tool in tumor diagnosis and treatment; antitumor agents
08/04/2005US20050170421 Using concentration of d-glactosides as diagnostic in detection of cancer; antitumor agents; immunoassay
08/04/2005US20050170420 Bacterial shuttle vectro for transfer of heterologous nucleotide sequences into cells; improving exogenous gene expression
08/04/2005US20050170417 A mutated G-CSF protein having a deletion of an amino acid sequence corresponding to an exon 3 region for use as a diagnostic cancer marker.
08/04/2005US20050170416 Accurate, economical and simple diagnosis of a variety of cancers based on the finding that exon 3 skipping occurs during transcription of the G-CSF gene in cancer patients
08/04/2005US20050170413 Transport peptide amino acid sequences for use in identifying modulators for prevention and treatment of cell proliferative disorders; tissue target therapy; drug delivery
08/04/2005US20050170411 Genes and proteins involved in the biosynthesis of enediyne ring structures
08/04/2005US20050170410 Recombinant cytokine for diagnosis, prevention and treatment of tissue-degenerating disorders
08/04/2005US20050170408 Recombinant g protein coupled receptor for use in identifying modulators for prevention and treatment of cell proliferative disorders
08/04/2005US20050170407 Reagents and methods useful for detecting diseases of the lung
08/04/2005US20050170406 Using Burkitt's lymphoma-172 nucleotide sequences as diagnostic, prognostic and imaging tool in detection and treatment of infection and cell proliferative disorders of urogenital system
08/04/2005US20050170404 Modified human growth hormone polypeptides and their uses
08/04/2005US20050170399 Determining whether a human is at risk for development of autosomal dominant polycystic kidney disease by detecting the presence of a mutated PKD2 gene in nucleic acid of the subject
08/04/2005US20050170398 Producing three or more non-identical antibodies in a single recombinant host cell in which a nucleic acid sequence encoding a light chain and nucleic acid sequences encoding different heavy chains are expressed
08/04/2005US20050170397 Novel receptors
08/04/2005US20050170396 Using monoclonal antibodies to determine concentration of preferential membrane bound receptor in cancer cells; immunoassay
08/04/2005US20050170393 Using organic anion transporter polypeptide-related protein (OATPB) as diagnostic tool in detecting modulators for prevention and treatment of nervous system disorders
08/04/2005US20050170391 TAUT1 transporters expressed in blood brain barrier cells
08/04/2005US20050170389 Nucleotide sequences coding ligand polypeptides for use in identifying modulators for diagnosis, prevention and treatnment of diabetes, heart and cancer disorders
08/04/2005US20050170384 Expression vector comprising nucleotide sequences coding protein with sequence similarities to chordin proteins for use as tool in identifying modulator for treatment and prevention of infection and metabolic disorders
08/04/2005US20050170380 Ribosomal protein for treatment, diagnosis and prevention of cell proliferative, atherosclerotic and nervous system disorders
08/04/2005US20050170374 Expression vector comprising nucleotide sequences coding protein factor for treatment, diagnosis and prevention of proliferative and differentiative disorders
08/04/2005US20050170368 Tumor-associated antigenic target polypeptides for use as tools in treatment of cell proliferative disorders; antitumor and/or antiproliferative agents
08/04/2005US20050170366 Novel hair keratin-associated proteins
08/04/2005US20050170363 For conjugation with biomolecules, drugs, and toxins
08/04/2005US20050170357 Nucleotide sequences comprising Birt-Hogg-Dubé locus (BHD) for use in identifying modulator for treatment of cell proliferative disorders of kidney; antisense agents; gene expression inhibition
08/04/2005US20050170348 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
08/04/2005US20050170344 Chds as modifiers of the p53 pathway and methods of use
08/04/2005US20050170343 Modulating insulin receptor signaling
08/04/2005US20050170337 Nucleotide sequences coding coiled-coil viral oligomer for identifying modulator for treatment and prevention of hepatitis; viricides
08/04/2005US20050169965 Compounds with improved cartilage-inducing and/or bone-inducing activity
08/04/2005US20050169943 Isolating outer membrane preparation, immunogenic component or extract from commensal Neisseria and formulating
08/04/2005US20050169942 Novel DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain for production of therapeutics
08/04/2005US20050169939 Produced in cultured cells without Marek's disease contamination
08/04/2005US20050169937 Attacking immune tolerant species; having at least one consensus amino acid sequence
08/04/2005US20050169936 Epithelial cell growth inhibitors
08/04/2005US20050169935 Compositions and methods for immunotherapy of cancer and infectious diseases
08/04/2005US20050169934 Computer assisted modeling of tumor antigen bound in major histocompatibility complex I groove; substituting at least first amino acid located in cytotoxic T lymphocyte epitope; reducing interference with T cell receptor binding; HER-2 related cancer
08/04/2005US20050169930 PSCA: prostate stem cell antigen and uses thereof
08/04/2005US20050169928 Antibodies which bind to proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes
08/04/2005US20050169925 variable regions peptides for immunizing against amyloid plaque formation; biodrug for dementia, Alzheimer's disease, neuropathy, Down's syndrome, Creutzfeld Jacob disease, Parkinson's disease, amyotropic lateral sclerosis; neuroprotectants; hemostatic agent
08/04/2005US20050169923 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug
08/04/2005US20050169922 drug screening for compounds that enhance or suppress killer T cell activity by contacting killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
08/04/2005US20050169919 DNA encoding the amino acid sequence fusion protein; regulate T cell interactions with B7 positive cells, immune responses; treating tissue transplant rejection, graft versus host disease with immunomodulator; antiproliferative agent of lymphocyte
08/04/2005US20050169917 Orphanin FQ receptor
08/04/2005US20050169914 Novel functions for decay accelerating factor (DAF) in inflammation
08/04/2005US20050169904 biodrug fusion protein comprising active mitochondrial protein or peptide, a mitochondrial membrane-permeant peptide and linking to a mitochondrial targeting sequence; targeting sequence is cleaved within the mitochondrial matrix, and not cleaved within the cellular cytoplasm; mitochondrial disorders
08/04/2005US20050169900 inhibit proliferation of the malignant tumor by administering to the subject a plurality of a genetically manipulated cell which expresses cytokines, cellular adhesion molecules, immunostimulants, tumor associated antigens and tumor specific antigens; biodrugs as anticarcinogenic agents
08/04/2005US20050169892 Adeno-associated virus materials and methods
08/04/2005US20050169891 Tissue tropism of a virus capsid, of protein fragments from different viruses, adenovirus of subgroup C or subgroup B
08/04/2005US20050169885 Recombinant super-compound interferon
08/04/2005US20050169870 Methods of modulating CD200
08/04/2005US20050169853 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with Porphyromonas gingivalis
08/04/2005US20050166782 Printed materials comprising a support having an oligomer and/or a polymer applied thereon, a method for preparing the same and a method for delivering and/or storing the same
08/04/2005CA2554585A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
08/04/2005CA2554472A1 Lawsonia intracellularis subunit vaccines
08/04/2005CA2553828A1 Expression of apoa-1 and variants thereof using spliceosome mediated rna trans-splicing
08/04/2005CA2553757A1 Gene markers linked to fusarium head blight-resistance factor and utilization thereof
08/04/2005CA2553756A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications
08/04/2005CA2553745A1 Mutant sodium channel nav1.7 and methods related thereto
08/04/2005CA2553541A1 Chimpanzee adenovirus vaccine carriers
08/04/2005CA2553503A1 Expression of mammalian proteins in pseudomonas fluorescens
08/04/2005CA2553456A1 Primary central nervous system tumor specific behab isoforms
1 ... 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 ... 2916